₹346.6
▼ -7.91 -2.23%
As of 10 Sept 2026 · delayed
BSE Listed · Pharmaceuticals
FDC Ltd. (531599)
Volume: 1,985Avg Vol 1W: 4,368Avg Vol 1M: 6,16052W Range:₹314.75₹528.3
Key Ratios
Checked 3h agoMarket Cap₹5,643 Cr
Current Price₹346.6
Previous Close₹354.51
High / Low (52w)₹528.3 / ₹314.75
Volume1,985
Avg Vol (1W)4,368
Avg Vol (1M)6,160
Stock P/E18.33
Book Value₹152.64
Dividend Yield1.41%
ROE11.32%
ROA10.02%
Revenue (TTM)—
Revenue Growth8.5%
Profit Margin13.36%
Total Debt₹10,97,000 Cr
Shares Outstanding16 Cr
Face Value₹1
EPS (TTM)₹18.91
P/B2.27
Debt / Equity0.01
50 DMA₹382.01
200 DMA₹382.41
Day change-2.23%
Price Chart
₹346.6▼ 24.55% · 1Y
2025-09-102026-09-10
20-day avg volume: 6K shares
Pros
- Company is almost debt-free.
- Revenue grew 16% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹514 Cr | ₹464 Cr | ₹492 Cr | ₹648 Cr | ₹473 Cr | ₹465 Cr | ₹585 Cr | ₹668 Cr |
| EBITDA | ₹91 Cr | ₹52 Cr | ₹55 Cr | ₹161 Cr | ₹39 Cr | ₹58 Cr | ₹142 Cr | ₹176 Cr |
| Net Profit | ₹72 Cr | ₹37 Cr | ₹39 Cr | ₹121 Cr | ₹28 Cr | ₹28 Cr | ₹103 Cr | ₹132 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,199 Cr | ₹482 Cr | ₹642 Cr | ₹462 Cr | ₹458 Cr | ₹564 Cr | ₹2,284 Cr | ₹655 Cr |
| EBITDA | ₹362 Cr | ₹69 Cr | ₹162 Cr | ₹41 Cr | ₹57 Cr | ₹144 Cr | ₹400 Cr | ₹175 Cr |
| Net Profit | ₹267 Cr | ₹48 Cr | ₹122 Cr | ₹29 Cr | ₹27 Cr | ₹107 Cr | ₹281 Cr | ₹132 Cr |
| EPS | 16.39 | — | — | — | — | — | 17.29 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,640 Cr | ₹1,813 Cr | ₹1,956 Cr | ₹2,270 Cr | ₹2,343 Cr | ₹2,468 Cr | ₹2,714 Cr | ₹2,919 Cr |
| Total Liabilities | ₹195 Cr | ₹266 Cr | ₹222 Cr | ₹314 Cr | ₹362 Cr | ₹371 Cr | ₹433 Cr | ₹434 Cr |
| Equity | ₹1,445 Cr | ₹1,547 Cr | ₹1,734 Cr | ₹1,956 Cr | ₹1,981 Cr | ₹2,097 Cr | ₹2,281 Cr | ₹2,485 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹186 Cr | ₹335 Cr | ₹302 Cr | ₹241 Cr | ₹232 Cr | ₹325 Cr | ₹420 Cr | ₹288 Cr |
| Investing | ₹-120 Cr | ₹-98 Cr | ₹-77 Cr | ₹-145 Cr | ₹11 Cr | ₹-17 Cr | ₹-200 Cr | ₹-110 Cr |
| Financing | ₹0 Cr | ₹-142 Cr | ₹-129 Cr | ₹-10 Cr | ₹-180 Cr | ₹-202 Cr | ₹-92 Cr | ₹-93 Cr |
| Free Cash Flow | ₹186 Cr | ₹335 Cr | ₹302 Cr | ₹241 Cr | ₹232 Cr | ₹325 Cr | ₹420 Cr | ₹288 Cr |
Shareholding
Promoter 69.66% Institutions 7.71% Public 22.63%
Efficiency & Working Capital
ROCE15.2%
Interest Coverage76.1
Dividend Payout—
Debtor Days26 d
Inventory Days60 d
Payable Days35 d
Cash Conversion Cycle50 d
Working Capital Days85 d
Shareholding Details
As of 2026-06-30
Promoter69.7%
FII1.4%
DII6.3%
Institutions7.7%
Public22.6%
Promoter Pledge0%
No. of Shareholders55,045
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% | 69.7% |
| FIIs | 2.4% | 2.4% | 2.6% | 2.5% | 2.6% | 2.7% | 2.6% | 2.4% | 2.4% | 2.3% | 2.4% | 1.4% |
| DIIs | 8% | 7.6% | 6.9% | 6.7% | 6% | 6.1% | 6.4% | 7.2% | 6.8% | 6.3% | 6.3% | 6.3% |
| Public | 19.9% | 20.3% | 20.8% | 21.1% | 21.7% | 21.6% | 21.4% | 20.8% | 21.1% | 21.8% | 21.6% | 22.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 56,928 | 55,341 | 52,377 | 50,634 | 55,400 | 55,228 | 53,880 | 54,445 | 54,157 | 53,788 | 52,730 | 55,045 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Nomita R Chandavarkar | Shareholding of Promoter and Promoter Group | 22.7% | 3.69 Cr |
| Nandan Mohan Chandavarkar (in The Capacity Of Trustee Of Sandhya Mohan Chandavarkar Trust) | Shareholding of Promoter and Promoter Group | 12.5% | 2.03 Cr |
| Nandan Mohan Chandavarkar (in The Capacity Of Trustee Of Mohan Anand Chandavarkar Trust) | Shareholding of Promoter and Promoter Group | 12.5% | 2.03 Cr |
| Leo Advisors Pvt Ltd (trustee Of Ameya Family Discretionary Trust) | Shareholding of Promoter and Promoter Group | 9.2% | 1.49 Cr |
| Aditi C Bhanot | Shareholding of Promoter and Promoter Group | 6.8% | 1.11 Cr |
| Ameya Ashok Chandavarkar | Shareholding of Promoter and Promoter Group | 6.1% | 99,23,930 |
| Icici Prudential Smallcap Fund | Public Shareholding | 2.8% | 45,58,904 |
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | Public Shareholding | 2.6% | 42,75,331 |
| Nandan Mohan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 11,000 |
| Virgo Advisors Pvt Ltd (trustee Of Aditi Family Discretionary Trust) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Meera Ramdas Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mohan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sandhya Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Alpana Nandan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anandi Nandan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shivani Nandan Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vasant Anand Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Capt. Girish Anand Kaushik | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ashok Anand Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mangala Ashok Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shaivi Ameya Chandavarkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shreya Ameya Chandavar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Veera Ameya Chandavar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Aryatara Traders Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rohit Bhanot | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Mohan A Chandavarkar | ED / MD / Promoter | 2025 |
| Nandan M Chandavarkar | Executive Director / JMD / WTD | 2025 |
| Ashok A Chandavarkar | WTD & Executive Director | 2025 |
| Ameya A Chandavarkar | ED / CEO - International Business / Promoter | 2025 |
| Nomita R Chandavarkar | Non-Exec & Non-Independent Dir | 2025 |
| Mahesh Bijlani | Independent Non Exe. Director | 2025 |
| Vijay Maniar | Independent Non Exe. Director | 2025 |
| Vijay N Bhatt | Independent Non Exe. Director | 2025 |
| Charuta Nityanath Mandke | Independent Non Exe. Director | 2025 |
| Varsharani Katre | CS / Compliance Officer / Legal Head | 2025 |
| Kishore Saletore | Additional Independent Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,806 Cr | 84.9% |
| USA | ₹98 Cr | 4.6% |
| Others | ₹222 Cr | 10.5% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 29 | 16 | 16 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-05 | Board Meetings | — |
| dividend | 2026-02-11 | ₹5 (500%) | Interim 1 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 8 | 0 | 0 | 16 | 64 | 87 |
| 2025 | 0 | 0 | 0 | 16 | 64 | 79 |
| 2025 | 8 | 0 | 0 | 0 | 0 | 8 |
Insider / Designated-Person Trades
5 recent disclosure(s)
NANDAN MOHAN CHANDAVARKAR In the capacity of Trustee Sandhya Mohan Chandavarkar TrustAcquisition · 23,59,770
NANDAN MOHAN CHANDAVARKAR In the capacity of Trustee Mohan Anand Chandavarkar TrustAcquisition · 26,70,316
NANDAN MOHAN CHANDAVARKARDisposal · 50,30,086
Aditi C BhanotAcquisition · 99,56,821
Virgo Advisors Private LimitedDisposal · 99,56,821
Substantial Acquisitions (SAST)
7 disclosure(s)
Off Market / Inter se transfer24/06/2026 · —
Off Market / Inter se transfer24/06/2026 · 50,30,086
Off Market / Inter se transfer24/06/2026 · —
Inter-se Transfer17/02/2026 · 99,56,821
Inter-se Transfer17/02/2026 · 99,56,821
-17/02/2026 · 99,56,821
Company Information
🌐 www.fdcindia.com ↗
📍 B-8 MIDC Industrial Area, Waluj Dist, AURANGABAD, Maharashtra, 431136
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search